These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1190 related articles for article (PubMed ID: 12637337)

  • 1. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression.
    Zhan Y; Kim S; Izumi Y; Izumiya Y; Nakao T; Miyazaki H; Iwao H
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):795-801. PubMed ID: 12637337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential contribution of three mitogen-activated protein kinases to PDGF-BB-induced mesangial cell proliferation and gene expression.
    Kawano H; Kim S; Ohta K; Nakao T; Miyazaki H; Nakatani T; Iwao H
    J Am Soc Nephrol; 2003 Mar; 14(3):584-92. PubMed ID: 12595493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of extracellular signal-regulated protein kinases (ERKs) 1 and 2 by cAMP and dissociation of ERK inhibition from anti-mitogenic effects in rabbit vascular smooth muscle cells.
    Cospedal R; Lobo M; Zachary I
    Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):407-14. PubMed ID: 10455028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-derived growth factor-BB, insulin-like growth factor-I, and phorbol ester activate different signaling pathways for stimulation of vascular smooth muscle cell migration.
    Pukac L; Huangpu J; Karnovsky MJ
    Exp Cell Res; 1998 Aug; 242(2):548-60. PubMed ID: 9683541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baicalin inhibits PDGF-BB-stimulated vascular smooth muscle cell proliferation through suppressing PDGFRβ-ERK signaling and increase in p27 accumulation and prevents injury-induced neointimal hyperplasia.
    Dong LH; Wen JK; Miao SB; Jia Z; Hu HJ; Sun RH; Wu Y; Han M
    Cell Res; 2010 Nov; 20(11):1252-62. PubMed ID: 20661261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dominant negative c-Jun inhibits platelet-derived growth factor-directed migration by vascular smooth muscle cells.
    Ioroi T; Yamamori M; Yagi K; Hirai M; Zhan Y; Kim S; Iwao H
    J Pharmacol Sci; 2003 Feb; 91(2):145-8. PubMed ID: 12686758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rat aortic smooth muscle cell density affects activation of MAP kinase and Akt by menadione and PDGF homodimer BB.
    Li XA; Bianchi C; Sellke FW
    J Surg Res; 2001 Oct; 100(2):197-204. PubMed ID: 11592793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligustrazine attenuates the platelet-derived growth factor-BB-induced proliferation and migration of vascular smooth muscle cells by interrupting extracellular signal-regulated kinase and P38 mitogen-activated protein kinase pathways.
    Yu L; Huang X; Huang K; Gui C; Huang Q; Wei B
    Mol Med Rep; 2015 Jul; 12(1):705-11. PubMed ID: 25738255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene transfer of dominant-negative mutants of extracellular signal-regulated kinase and c-Jun NH2-terminal kinase prevents neointimal formation in balloon-injured rat artery.
    Izumi Y; Kim S; Namba M; Yasumoto H; Miyazaki H; Hoshiga M; Kaneda Y; Morishita R; Zhan Y; Iwao H
    Circ Res; 2001 Jun; 88(11):1120-6. PubMed ID: 11397777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p38 MAP kinase mediates platelet-derived growth factor-stimulated migration of hepatic myofibroblasts.
    Tangkijvanich P; Santiskulvong C; Melton AC; Rozengurt E; Yee HF
    J Cell Physiol; 2002 Jun; 191(3):351-61. PubMed ID: 12012331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphoinositide-dependent kinase 1 and p21-activated protein kinase mediate reactive oxygen species-dependent regulation of platelet-derived growth factor-induced smooth muscle cell migration.
    Weber DS; Taniyama Y; Rocic P; Seshiah PN; Dechert MA; Gerthoffer WT; Griendling KK
    Circ Res; 2004 May; 94(9):1219-26. PubMed ID: 15059930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of fenofibrate on neointima hyperplasia via G(0)/G(1) arrest of cell proliferation.
    Lee JJ; Yu JY; Zhang WY; Kim TJ; Lim Y; Kwon JS; Kim DW; Myung CS; Yun YP
    Eur J Pharmacol; 2011 Jan; 650(1):342-9. PubMed ID: 21040719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of MAP kinases and their cross-talk in TGF-beta1-induced apoptosis in FaO rat hepatoma cell line.
    Park HJ; Kim BC; Kim SJ; Choi KS
    Hepatology; 2002 Jun; 35(6):1360-71. PubMed ID: 12029621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1beta inhibits PDGF-BB-induced migration by cooperating with PDGF-BB to induce cyclooxygenase-2 expression in baboon aortic smooth muscle cells.
    Englesbe MJ; Deou J; Bourns BD; Clowes AW; Daum G
    J Vasc Surg; 2004 May; 39(5):1091-6. PubMed ID: 15111866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
    Chuang SM; Wang IC; Yang JL
    Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II stimulates platelet-derived growth factor-B chain expression in newborn rat vascular smooth muscle cells and neointimal cells through Ras, extracellular signal-regulated protein kinase, and c-Jun N-terminal protein kinase mechanisms.
    Deguchi J; Makuuchi M; Nakaoka T; Collins T; Takuwa Y
    Circ Res; 1999 Oct; 85(7):565-74. PubMed ID: 10506481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene transfer of redox factor-1 inhibits neointimal formation: involvement of platelet-derived growth factor-beta receptor signaling via the inhibition of the reactive oxygen species-mediated Syk pathway.
    Lee HM; Jeon BH; Won KJ; Lee CK; Park TK; Choi WS; Bae YM; Kim HS; Lee SK; Park SH; Irani K; Kim B
    Circ Res; 2009 Jan; 104(2):219-27, 5p following 227. PubMed ID: 19038866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II-augmented migration of VSMCs towards PDGF-BB involves Pyk2 and ERK 1/2 activation.
    Blaschke F; Stawowy P; Kappert K; Goetze S; Kintscher U; Wollert-Wulf B; Fleck E; Graf K
    Basic Res Cardiol; 2002 Jul; 97(4):334-42. PubMed ID: 12111044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of platelet-derived growth factor-induced p38 mitogen-activated protein kinase activation in vascular smooth muscle cells.
    Yamaguchi H; Igarashi M; Hirata A; Tsuchiya H; Susa S; Tominaga M; Daimon M; Kato T
    Eur J Clin Invest; 2001 Aug; 31(8):672-80. PubMed ID: 11473568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-derived growth factor-BB-induced hypertrophy of peritubular smooth muscle cells is mediated by activation of p38 MAP-kinase and of Rho-kinase.
    Romano F; Chiarenza C; Palombi F; Filippini A; Padula F; Ziparo E; De Cesaris P
    J Cell Physiol; 2006 Apr; 207(1):123-31. PubMed ID: 16270352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.